| PERIOD ENDING | 29-Aug-09 | 30-May-09 | 28-Feb-09 | 29-Nov-08 | | Total Revenue | 290,600 | 267,229 | 364,148 | 256,864 | | Cost of Revenue | 195,914 | 190,171 | 248,617 | 190,280 | | | Gross Profit | 94,686 | 77,058 | 115,531 | 66,584 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 70,431 | 77,983 | 83,451 | 81,060 | | Non Recurring | 1,612 |
-
| 30,513 | 23 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 22,643 | (925) | 1,567 | (14,499) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 107 | 104 | 128 | 194 | | Earnings Before Interest And Taxes | 22,750 | (821) | 1,695 | (14,305) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 22,750 | (821) | 1,695 | (14,305) | | Income Tax Expense | 8,637 | (215) | 2,900 | (5,462) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 14,113 | (606) | (1,205) | (8,843) | | | Non-recurring Events | | Discontinued Operations | (14,987) | (2) | (156) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (874) | (608) | (1,361) | (8,843) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($874) | ($608) | ($1,361) | ($8,843) |
|
0.31% Nasdaq 0.00%
Income Statement
